title: Drug-induced dermatomyositis after zoledronic acid.
abstract: A 57-year-old woman with prior exposure to bisphosphonates developed myalgia, proximal muscle weakness and lichenoid rash over the upper extremities and face 3 days after infusion of zoledronic acid for the management of osteoporosis. The diagnosis of dermatomyositis was made on the basis of clinical, laboratory and histological findings. This is the first report of drug-induced dermatomyositis secondary to zoledronic acid.
authors.affiliation: Department of Dermatology, Sir Charles Gairdner Hospital Dermatopathology WA School of Pathology and Laboratory Medicine, University of Western Australia, Perth, WA 6009, Australia. philipleitong@gmail.com
authors.forename: Philip L
authors.initials: PL
authors.lastname: Tong
authors.forename: Lawrence L
authors.initials: LL
authors.lastname: Yu
authors.forename: Jonathan J
authors.initials: JJ
authors.lastname: Chan
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D003882:Dermatomyositis / Q000139:chemically induced*; D004164:Diphosphonates / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid